US Chemical Company Albemarle Opens a Center of Excellence SSC in Budapest
US chemical company Albemarle Corporation, a global leader in delivering innovative specialty chemicals, clean energy solutions and outstanding sustainability practices, opened a USD1 million service center in Budapest on Wednesday.
International Survey says Hungary is a Regional First in Biotech
San Francisco-based Burrill & Company’s, comprising biotech analysts and investment consultants, has published its latest annual report.
Green Power Plant Inaugurated by Hungarian-Japanese Investors
Hungarian and Japanese investors inaugurated a HUF 14 billion, 20MW biomass-fueled power plant in Szakoly (NE Hungary) on Thursday.
Government Action Plan Aims to Make Better Use of Resources for Drug Industry
A government action plan supporting R+D and medical biotechnology in Hungary's drug industry aims to increase competitiveness.
Drugmaker Egis to Launch New R&D Hub in Budapest
Hungarian pharmaceutical Egis is about to set up a new research and development center in Budapest
AMRI Opens Research Centre in Hungary
US pharmaceutical company AMRI opened its research center in Budapest on June 24, the company announced.
The center reportedly cost several million USD.
Kv Pharmaceutical Company Entered Into an Agreement with Gedeon Richter
KV Pharmaceutical Company on 19 June announced that it entered into an agreement with Gedeon Richter, Plc. of Budapest, Hungary, and jointly with Gedeon Richter USA for licensing rights to some of KV’s technologies and products in Women’s Health.
Richter Increased Its Profit in Q1
Gedeon Richter Plc Sales amounted to HUF 61,338 million (EUR 206.7 million) in the three months to March 2009, a 7.6 pct increase (in Euro terms 6.0 pct decline) when compared with the same period of 2008.
OMV Sold its Stake in Mol to Russian Oil Company
Austrian oil and gas company OMV has sold its 21.2 pct stake in Hungarian peer Mol to Russian oil company Surgutneftegas for EUR 1.4 billion, OMV announced on March 30.
Richter Q4 Profit More Than Doubles on Higher Revenue, Financial Income
Hungarian drug maker Gedeon Richter’s consolidated Q4 after-tax profit jumped 136.4 pct to HUF 15.9 billion from the same period a year earlier.
